title: Thrombomodulin levels are not modified during thalidomide treatment.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Zappasodi
authors.forename: Silvia
authors.initials: S
authors.lastname: Mangiacavalli
authors.forename: Virginio
authors.initials: V
authors.lastname: Terulla
authors.forename: Francesca
authors.initials: F
authors.lastname: Airò
authors.forename: Catherine
authors.initials: C
authors.lastname: Klersy
authors.forename: Marzia
authors.initials: M
authors.lastname: Varettoni
authors.forename: Alessandro
authors.initials: A
authors.lastname: Corso
mesh_terms: D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D009101:Multiple Myeloma / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D013792:Thalidomide / Q000008:administration & dosage*; D018180:Thrombomodulin / Q000097:blood*; D013927:Thrombosis / Q000097:blood* / Q000209:etiology
chemical_list: D007166:Immunosuppressive Agents; D018180:Thrombomodulin; D013792:Thalidomide